ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 625500 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 625500; 2) Community: the network communities that were significantly associated with the response to NSC 625500; 3) Molecule: the relationships between components within communities and NSC 625500; 4) MDR: the compounds that were significantly associated with the NSC 625500.

NSC Compound Enrichment Correlation
NSC 668261 Null 0.0185619722391417 0.59460509
NSC 698255 5'-Hydromethyl-2,5-bis-(2'selenyl)-N-methylpyrrol 0.0199123109106645 0.1632242
NSC 355457 11H-Indeno[1,2-c]isoquinolinium, 9-hydroxy-2,3,8-trimethoxy-6-methyl-, chloride 0.0209467683758283 0.18174276
NSC 113497 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) 0.0209467683758286 0.1270279
NSC 13151 Null 0.0209467683758286 0.24115742
NSC 303861 L-Cysteine analog 0.0209467683758286 0.49862325
NSC 328410 Camptothecin Derivative 0.0209467683758286 -0.058240321
NSC 33570 Null 0.0209467683758286 0.21509234
NSC 39215 Null 0.0209467683758286 0.67602069
NSC 642947 Methanone, [3-(dibromomethyl)-6-chloroquinolin-2-yl] phenyl- 0.0209467683758286 0.26276189
Total:55  Current:25    [First] [Prev] [Next] [Last]